• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

最初被误诊为曲霉病的肺肉瘤样癌:一项诊断挑战。

Pulmonary Sarcomatoid Carcinoma Initially Misdiagnosed as Aspergillosis: A Diagnostic Challenge.

作者信息

Qian YingYing

机构信息

Department of Geriatrics, Second Affiliated Hospital, School of Medicine Zhejiang University Hangzhou China.

出版信息

Respirol Case Rep. 2025 May 19;13(5):e70213. doi: 10.1002/rcr2.70213. eCollection 2025 May.

DOI:10.1002/rcr2.70213
PMID:40395487
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12089655/
Abstract

Pulmonary sarcomatoid carcinoma (PSC) is a rare and aggressive malignancy that often presents atypically, leading to incomplete diagnosis. We report a 55-year-old male with chronic obstructive pulmonary disease who presented with productive cough and haemoptysis. Initial bronchoscopy revealed fungal hyphae consistent with Aspergillus infection. The misleading clinical presentation led to an incomplete diagnosis. Subsequent lung biopsy and immunohistochemistry confirmed PSC harbouring an EGFR L858R mutation. Despite the presence of a targetable mutation, the patient showed a poor response to EGFR-targeted therapy. This case highlights the diagnostic challenges and therapeutic complexities when PSC coexists with an airway fungal infection.

摘要

肺肉瘤样癌(PSC)是一种罕见且侵袭性强的恶性肿瘤,通常表现不典型,导致诊断不完整。我们报告一例55岁患有慢性阻塞性肺疾病的男性,表现为咳痰和咯血。最初的支气管镜检查发现符合曲霉菌感染的真菌菌丝。这种具有误导性的临床表现导致诊断不完整。随后的肺活检和免疫组化证实为携带表皮生长因子受体(EGFR)L858R突变的PSC。尽管存在可靶向的突变,但该患者对EGFR靶向治疗反应不佳。该病例突出了PSC与气道真菌感染共存时的诊断挑战和治疗复杂性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc3/12089655/b4ab50fbde82/RCR2-13-e70213-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc3/12089655/b47fc8374831/RCR2-13-e70213-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc3/12089655/b4ab50fbde82/RCR2-13-e70213-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc3/12089655/b47fc8374831/RCR2-13-e70213-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6dc3/12089655/b4ab50fbde82/RCR2-13-e70213-g003.jpg

相似文献

1
Pulmonary Sarcomatoid Carcinoma Initially Misdiagnosed as Aspergillosis: A Diagnostic Challenge.最初被误诊为曲霉病的肺肉瘤样癌:一项诊断挑战。
Respirol Case Rep. 2025 May 19;13(5):e70213. doi: 10.1002/rcr2.70213. eCollection 2025 May.
2
Response to gefitinib/crizotinib combination in a pulmonary sarcomatoid carcinoma patient harboring concurrent EGFR mutation and MET amplification.一名同时存在表皮生长因子受体(EGFR)突变和间充质上皮转化因子(MET)扩增的肺肉瘤样癌患者对吉非替尼/克唑替尼联合治疗的反应
Clin Case Rep. 2021 Jul 23;9(7):e04487. doi: 10.1002/ccr3.4487. eCollection 2021 Jul.
3
Pulmonary Sarcomatoid Carcinoma: What Makes This Rare Lung Cancer So Challenging?肺肉瘤样癌:是什么让这种罕见的肺癌如此具有挑战性?
Cureus. 2024 Jun 24;16(6):e63045. doi: 10.7759/cureus.63045. eCollection 2024 Jun.
4
Epidermal growth factor receptor mutation heterogeneity analysis of pulmonary sarcomatoid carcinoma successfully treated with erlotinib: A case report.厄洛替尼成功治疗的肺肉瘤样癌的表皮生长因子受体突变异质性分析:一例报告
Oncol Lett. 2015 May;9(5):2239-2243. doi: 10.3892/ol.2015.3057. Epub 2015 Mar 18.
5
Case Report: Pulmonary sarcomatoid carcinoma in a female patient from Nepal.病例报告:来自尼泊尔的一名女性患者的肺肉瘤样癌。
F1000Res. 2021 Aug 2;10:723. doi: 10.12688/f1000research.55187.1. eCollection 2021.
6
Case Report: Cracking the case: unique presentation of pulmonary sarcomatoid carcinoma with spherical lung metastases.病例报告:破解病例:肺肉瘤样癌伴球形肺转移的独特表现。
Front Med (Lausanne). 2025 Apr 25;12:1567046. doi: 10.3389/fmed.2025.1567046. eCollection 2025.
7
Pulmonary aspergillosis presenting with recurrent haemoptysis.以反复咯血为表现的肺曲霉病。
BMJ Case Rep. 2015 Jul 7;2015:bcr2015211249. doi: 10.1136/bcr-2015-211249.
8
Case report: an initially unresectable stage III pulmonary sarcomatoid carcinoma qith EGFR mutation achieving pathological complete response following neoadjuvant therapy with osimertinib plus chemotherapy.病例报告:一例初始不可切除的Ⅲ期肺肉瘤样癌,伴有表皮生长因子受体(EGFR)突变,在接受奥希替尼联合化疗的新辅助治疗后达到病理完全缓解。
Front Oncol. 2022 Nov 25;12:1033322. doi: 10.3389/fonc.2022.1033322. eCollection 2022.
9
[A case of allergic bronchopulmonary mycosis caused by ].[由……引起的一例变应性支气管肺真菌病] (你提供的原文不完整,这里括号内是补充完整句子结构后的示意翻译)
Zhonghua Jie He He Hu Xi Za Zhi. 2025 May 12;48(5):464-469. doi: 10.3760/cma.j.cn112147-20240831-00523.
10
An advanced pulmonary sarcomatoid carcinoma patient harboring a BRAF mutation responds to dabrafenib and trametinib: a case report and literature review.一名携带BRAF突变的晚期肺肉瘤样癌患者对达拉非尼和曲美替尼有反应:病例报告及文献综述
Front Oncol. 2023 Jul 21;13:1220745. doi: 10.3389/fonc.2023.1220745. eCollection 2023.

本文引用的文献

1
Role of immunotherapy in pulmonary sarcomatoid carcinoma: review of current approaches and related biomarkers.免疫疗法在肺肉瘤样癌中的作用:当前方法及相关生物标志物综述
Ther Adv Med Oncol. 2024 May 6;16:17588359241249041. doi: 10.1177/17588359241249041. eCollection 2024.
2
Biological characteristics and clinical treatment of pulmonary sarcomatoid carcinoma: a narrative review.肺肉瘤样癌的生物学特性及临床治疗:一项叙述性综述
Transl Lung Cancer Res. 2024 Mar 29;13(3):635-653. doi: 10.21037/tlcr-24-127. Epub 2024 Mar 27.
3
Acute Invasive Pulmonary Aspergillosis: Clinical Presentation and Treatment.
急性侵袭性肺曲霉病:临床表现与治疗。
Semin Respir Crit Care Med. 2024 Feb;45(1):69-87. doi: 10.1055/s-0043-1777769. Epub 2024 Jan 11.
4
Pathogenesis of Respiratory Viral and Fungal Coinfections.呼吸道病毒和真菌合并感染的发病机制。
Clin Microbiol Rev. 2022 Jan 19;35(1):e0009421. doi: 10.1128/CMR.00094-21. Epub 2021 Nov 17.
5
Targeted Therapy Approaches for MET Abnormalities in Non-Small Cell Lung Cancer.针对非小细胞肺癌中 MET 异常的靶向治疗方法。
Drugs. 2021 Apr;81(5):547-554. doi: 10.1007/s40265-021-01477-2. Epub 2021 Feb 27.
6
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.全面基因组分析显示,肺肉瘤样癌通常存在潜在可靶向的基因组改变或高肿瘤突变负担。
J Thorac Oncol. 2017 Jun;12(6):932-942. doi: 10.1016/j.jtho.2017.03.005. Epub 2017 Mar 16.